Delivery Order SPE2DB22D1106-SPE2DB24FEQB5
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $31,648.98 firm fixed price delivery order is for the provision of 4564159083 - BUPROPION HCL XL 300 MG TABLET 500S. The award is associated with a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that was previously awarded to Amerisourcebergen...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,068.28 firm-fixed-price delivery order is for the supply of Bupropion HCL XL 300 MG tablets. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This federal contract award, with ID SPE2DX15D1205|SPE2DX24F47Y7, is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the supply of BUPROPION HCL XL 300 MG TABLET 500S to the Defense Logistics Agency (DLA) Troop Support Medical, a civilian agency that supports the Department of Defense. The contract has a ceiling value of $40,709.02 and a completion date of February 6, 2024. It is a firm...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,539.90 firm fixed-price delivery order is for the supply of 500 count BUPROPION HCL XL 150 MG tablets. The contract has an ultimate completion date of January 18, 2024. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,890.10 firm fixed-price delivery order contract is for the supply of BUPROPION HCL XL 300 MG TABLET 500S, a generic pharmaceutical product. The contract has an ultimate completion date of February 20, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,876.60, is for the delivery of Bupropion HCL XL 300 mg tablets and is a firm fixed-price delivery order with a completion date of May 1, 2024. The contract is not designated as a set-aside and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, valued at $20,953.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC enables the DLA to procure a comprehensive range of pharmaceutical products and medical supplies, including specialty...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $31,989.14 delivery order contract is for the supply of 4564327587 - Bupropion HCL XL 300 mg Tablets, 500 count. The contract has an ultimate completion date of April 19, 2024 and is a firm fixed price arrangement. Amerisourcebergen, a major pharmaceutical distribution company, is delivering these prescription medications under an Indefinite Delivery...
- This federal contract award, with identification number SPE2DB24D2011|SPE2DB24FBNYF, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Bupropion HCL XL 300 mg tablets, a pharmaceutical product, with a ceiling value of $13,838.52 and a completion date of March 13, 2024. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and does not have a...
- This federal contract award, valued at $9,151.31, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is a delivery order contract for the supply of BUPROPION HCL XL 300 MG TABLET 500S, with a completion date of February 13, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FEQB5Delivery Order
This federal contract award, SPE2DB22D1106|SPE2DB24FEQB5, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $57,864.18 firm fixed-price delivery order is for the supply of 4564491257 - BUPROPION HCL XL 300 MG TABLET 500S, with a completion date of May 6, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The current award is not set-aside and was competed openly.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $57.9k | 5/3/24 |